Valuation: Artemis Global Life Sciences Limited

Market Cap 3.27B 2.81B 2.64B 2.41B 4.54B 312B 4.57B 31.2B 12.09B 157B 12.29B 12.02B 522B P/E 2018
24.6x
P/E 2019 19.4x
Enterprise Value 4.29B 3.68B 3.46B 3.16B 5.96B 409B 5.99B 40.91B 15.85B 206B 16.11B 15.76B 684B EV / Sales 2018
1.44x
EV / Sales 2019 0.91x
Free-Float
-
Yield 2018 *
-
Yield 2019 -
19-08-13 Artemis Global Life Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2019 CI
19-05-09 Artemis Global Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2019 CI
19-05-09 Artemis Global Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019 CI
19-02-04 Artemis Global Life Sciences Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018 CI
18-11-12 Artemis Global Life Sciences Limited Announces Unaudited Standalone and Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018 CI
18-08-20 Artemis Global Life Sciences Limited Reports Audited Consolidated and Standalone and Earnings Results for the Year Ended March 31, 2018 CI
18-08-03 Artemis Global Life Sciences Limited Announces Unaudited Standalone and Consolidated Earnings Results for First Quarter Ended June 30, 2018 CI
18-05-09 Artemis Global Life Sciences Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year and Consolidated Earnings Results for the Year Ended March 31, 2018 CI
18-02-05 Artemis Global Life Sciences Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017 CI
17-10-31 Artemis Global Life Sciences Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2017 CI
17-09-27 Artemis Global Life Sciences Limited Announces Management Appointments CI
17-08-04 Artemis Global Life Sciences Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2017 CI
17-08-04 Artemis Global Life Sciences Limited Announces Management Appointments CI

Financials

2018 2019
Net sales 5.03B 4.32B 4.05B 3.7B 6.98B 480B 7.02B 47.93B 18.58B 242B 18.88B 18.47B 801B 5.47B 4.69B 4.4B 4.02B 7.59B 521B 7.63B 52.1B 20.19B 263B 20.52B 20.07B 871B
Net income 263M 226M 212M 193M 365M 25.06B 367M 2.51B 971M 12.64B 987M 965M 41.88B 205M 176M 165M 151M 285M 19.55B 286M 1.95B 757M 9.86B 769M 753M 32.66B
Net Debt 775M 665M 624M 570M 1.08B 73.9B 1.08B 7.39B 2.86B 37.28B 2.91B 2.85B 123B 1.02B 874M 820M 749M 1.41B 97.1B 1.42B 9.71B 3.76B 48.98B 3.82B 3.74B 162B
Logo Artemis Global Life Sciences Limited
Artemis Global Life Sciences Limited is an India-based company engaged in the business of buying, selling, managing, improving, maintaining, taking on lease, promoting, administer, own or run hospitals, clinics, nursing homes, dispensaries. It is also engaged in the business of maternity homes, old age homes, health resorts and health clubs, polyclinics, medical centers, child welfare and family planning centers, diagnostic centers. The Company is also into all types of laboratories for carrying on investigation, x-ray, CAT scan, ECG and medical research and provision of all kinds of medical and health services and equipments. The objective of the Company is to buy, sell, manufacture or deal in all type of drugs, medicines including alternative/Ayurveda medicines pharmaceuticals, chemicals and colors used in drugs, medicines and pharmaceuticals and in their raw materials.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. AGLSL Stock